GIG
STAB

Goodnow Investment Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Goodnow Investment Group’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-28,023
Closed -$656K – 28
2013
Q4 		$656K Sell
28,023
-1,900
-6% -$51.7K 0.11% 26
2013
Q3 		$940K Sell
29,923
-171
-0.6% -$5.66K 0.15% 29
2013
Q2 		$951K Buy
+30,094
New +$1.04M 0.17% 31

Other funds holding STAB

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Goodnow Investment Group's STAB Position: Q1 2014 in Review

Goodnow Investment Group sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2014, closing a stake of 28,023 shares — an estimated $656K sold.

Goodnow Investment Group first reported a position in STAB in Q2 2013 and held it in 3 quarters. The position peaked at $951K in Q2 2013. 35 funds tracked by Wall St. Rank hold STAB as of Q1 2014.

  • Goodnow Investment Group reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Goodnow Investment Group sold 28,023 Statera Biopharma, Inc. Common Stock shares in Q1 2014, an estimated $656K.
  • Goodnow Investment Group first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
  • Goodnow Investment Group's Statera Biopharma, Inc. Common Stock position peaked at $951K in Q2 2013.
  • 35 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2014.

Based on Goodnow Investment Group's 13F filing for Q1 2014, filed 15 May 2014.